Shares of Joint Corp (NASDAQ:JYNT) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $6.15.
JYNT has been the topic of several research analyst reports. ValuEngine upgraded shares of Joint from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st. Zacks Investment Research lowered shares of Joint from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th.
Joint (NASDAQ:JYNT) opened at $4.85 on Thursday. Joint has a 52-week low of $3.06 and a 52-week high of $6.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market cap of $65.29, a P/E ratio of -7.03 and a beta of 1.53.
Large investors have recently modified their holdings of the business. Russell Investments Group Ltd. boosted its stake in shares of Joint by 24.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 87,900 shares of the company’s stock valued at $334,000 after buying an additional 17,500 shares during the period. Boston Partners boosted its stake in shares of Joint by 25.4% during the 3rd quarter. Boston Partners now owns 189,200 shares of the company’s stock valued at $901,000 after buying an additional 38,300 shares during the period. Finally, Skylands Capital LLC boosted its stake in shares of Joint by 11.0% during the 4th quarter. Skylands Capital LLC now owns 612,529 shares of the company’s stock valued at $3,038,000 after buying an additional 60,900 shares during the period. 45.24% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Joint Corp (JYNT) Given Average Rating of “Buy” by Analysts” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/18/joint-corp-jynt-given-average-rating-of-buy-by-analysts.html.
Joint Company Profile
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.